NCT07208227

In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 44 (actual)
• Sponsor: Pierre Fabre Dermo Cosmetique · Industry
• Sex: Female
• Age: 45 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Tolerance and efficacy study of an anti aging cream on 44 subjects aged between 45 and 65 years, with sensitive skin and deep wrinkles. This study is conducted as a national, monocentric, non-randomized open trial. Planning of the visits: * Visit 1: Inclusion (Day 1) * Visit 2: Intermediate visit (Day 29), a window of +48 hours is allowed * Visit 3: End of study (Day 57), a window of +72 hours is allowed The maximum duration of participation for a subject is 60 days.

Conditions

• Healthy
• Sensitive Skin
• Deep Wrinkles

Interventions

Type	Name	Description
OTHER	Face Cream RV4983A LA3365	Cosmetic face cream product applied once a day on face, neck and neckline.

Timeline

• Start date: 2021-10-27
• Primary completion: 2022-02-07
• Completion: 2022-02-07
• First posted: 2025-10-06
• Last updated: 2025-10-06

Locations

1 site across 1 country: Poland